Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/82038
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technology-
dc.creatorChow, LMCen_US
dc.creatorChan, THen_US
dc.creatorChan, KFen_US
dc.creatorWong, ILKen_US
dc.creatorLaw, MCen_US
dc.date.accessioned2020-05-05T05:58:24Z-
dc.date.available2020-05-05T05:58:24Z-
dc.identifier.urihttp://hdl.handle.net/10397/82038-
dc.language.isoenen_US
dc.rightsAssignee: The Hong Kong Polytechnic Universityen_US
dc.rightsAssignee: The Royal Institution for the Advancement of Learning/McGill Universityen_US
dc.titleAlkyne-, azide- and triazole-containing flavonoids as modulators for multidrug resistance in cancersen_US
dc.typePatenten_US
dc.description.otherinformationUS10208025; US10208025 B2; US10208025B2; US10,208,025; US10,208,025 B2; 10208025; Appl. No. 15/296,471en_US
dcterms.abstractA triazole bridged flavonoid dimer compound library was efficiently constructed via the cycloaddition reaction of a series of flavonoid-containing azides (Az 1-15) and alkynes (Ac 1-17). These triazole bridged flavonoid dimers and their precursor alkyne- and azide-containing flavonoids were screened for their ability to modulate multidrug resistance (MDR) in P-gp-overexpressed cell line (LCC6MDR), MRP1-overexpressed cell line (2008/MRP1) and BCRP-overexpressed cell line (HEK293/R2 and MCF7-MX100). Generally, they displayed very promising MDR reversal activity against P-gp-, MRP1- and BCRP-mediated drug resistance. Moreover, they showed different levels of selectivity for various transporters. Overall, they can be divided into mono-selective, dual-selective and multi-selective modulators for the P-gp, MRP1 and BCRP transporters. The EC.sub.50 values for reversing paclitaxel resistance (141-340 nM) of LCC6MDR cells, DOX (78-590 nM) and vincristine (82-550 nM) resistance of 2008/MRP1 cells and topotecan resistance (0.9-135 nM) of HEK293/R2 and MCF7-MX100 cells were at nanomolar range. Importantly, a number of compounds displayed EC.sub.50 at or below 10 nM in BCRP-overexpressed cell lines, indicating that these bivalent triazoles more selectively inhibit BCRP transporter than the P-gp and MRP1 transporters. Most of the dimers are notably safe MDR chemosensitizers as indicated by their high therapeutic index values.-
dcterms.bibliographicCitationUS Patent 10,208,025 B2. Washington, DC: US Patent and Trademark Office, 2019.en_US
dcterms.issued2019-02-19-
dc.description.countryUS-
dc.description.validate202006 bcrc-
dc.description.oaVersion of Recorden_US
Appears in Collections:Patent
Files in This Item:
File Description SizeFormat 
us10208025b2.pdf5.73 MBAdobe PDFView/Open
Show simple item record

Page views

28
Citations as of Jun 19, 2022

Downloads

2
Citations as of Jun 19, 2022

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.